- Proto Labs press release (NYSE:PRLB): Q4 Non-GAAP EPS of $0.46 beats by $0.16.
- Revenue of $125M (+8.1% Y/Y) beats by $2.28M.
- Adjusted EBITDA was $22.3 million, or 17.8% of revenue, compared to $14.5 million, or 12.5% of revenue, in the fourth quarter of 2022.
- Cash flow from operations was $73.3 million in 2023, compared to $62.1 million in 2022.
-
For the first quarter of 2024, the Company expects to generate revenue between $120 million and $128 million vs. $127.70M consensus.
The Company expects first quarter 2024 diluted net income per share between $0.09 and $0.17, and non-GAAP diluted net income per share between $0.26 and $0.34 vs. $0.34M consensus.
This guidance reflects a softer start to 2024, due to December 2023 and early January 2024 order levels being lower than historical periods. However, recent performance has been more in line with historical trends, and our guidance assumes that will continue through the end of March.
Proto Labs beats top-line and bottom-line estimates; initiates Q1 outlook
Recommended For You
About PRLB Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PRLB | - | - |
Proto Labs, Inc. |